The effect of clomiphene N-acetyl cysteine on the pregnancy rate
Phase 3
- Conditions
- PCO syndrome.Polycystic ovarian syndrome
- Registration Number
- IRCT2016042727638N1
- Lead Sponsor
- Vice President of Research Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 70
Inclusion Criteria
PCO patients having at least two of the three conditions for polycystic ovary syndrome based on Rotterdam criteria; age over 18 years, openness of at least one tubal patency based on HSG; normal spermogram; willingness to cooperate in the studying
Exclusion criteria: changes in the diagnosis of the patience during the research; hyperprolactinemia; hypothyroidism; existence of other endocrine diseases such as Cushing.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The number of follicle. Timepoint: 12th day of the cycle. Method of measurement: Measuring the number of ovarian follicles by transvaginal ultrasonography.;Follicle diameter. Timepoint: 12th day of the cycle. Method of measurement: Measuring the follicle diameter by transvaginal ultrasonography.;Endometrial thickness. Timepoint: 12th day of the cycle. Method of measurement: Measuring the endometrial thickness by transvaginal ultrasonography.;Pregnancy. Timepoint: 14 days after the HCG injection into the uterus. Method of measurement: Measurement The BetaHCG testing by blood tests.
- Secondary Outcome Measures
Name Time Method